Latest news with #SD
Yahoo
31-07-2025
- Sport
- Yahoo
🥇 NYCFC star leads the way in latest MLS Team of the Matchday
MLS has announced the Team of the Matchday for the 27th round of matches this past weekend. As ever, there were those who stood head and shoulders above the rest of their contemporaries across the league, highlighted by an otherworldly goalscoring performance by NYCFC's leading man. Here is the team selected by MLS. Full team (3-3-4, left to right) Starters: Pedro Gallese (ORL) - Jack Elliott (CHI), Manu Duah (SD), Mathias Laborda (VAN) - Martín Ojeda (ORL), Owen Wolff (ATX), J.C. Ngando (VAN) - Mikael Uhre (PHI), Alonso Martínez (NYC), Ramiro Enrique (ORL), Kelvin Yeboah (MIN) Coach: Oscar Pareja (ORL) Bench: Pablo Sisniega (SD), Benjamin Cremaschi (MIA), Cristhian Paredes (POR), Braian Ojeda (RSL), Maxi Moralez (NYC), Alexey Miranchuk (ATL), Osman Bukari (ATX), Ivan Angulo, Logan Farrington (DAL) What do you make the team selections? Would you change anything? Have your say! 📸 Editorial Photo Credit: © Tim Heitman | 2025 Jul 25 - Imagn Images
Business Standard
30-07-2025
- Business
- Business Standard
Fermenta Announces Granting of CEP by EDQM for VITADEE™ 100 SD, Enabling Accelerated Global Growth
PRNewswire Thane (Maharashtra) [India], July 30: Fermenta Biotech Limited ("Fermenta"), a pioneer in pharmaceutical and nutritional ingredients; one of the world's leading manufacturers of Vitamin D3, is pleased to announce that it has received the Certificate of Suitability (CEP) by the European Directorate for the Quality of Medicines & Healthcare (EDQM) for its Spray-Dried variant, VITADEE™ 100 SD - CHOLECALCIFEROL CONCENTRATE (POWDER FORM) 100, 000 IU/g being manufactured at its Kullu, Himanchal Pradesh facility. Fermenta now becomes one of the only two companies globally to hold a CEP for this variant of Vitamin D3. The approval underscores Fermenta's adherence to the stringent European Pharmacopoeial Standards for manufacturing and product quality. Commenting on the achievement, Mr Prashant Nagre, Managing Director of Fermenta, shared: "As we enter our 75th year, receiving the CEP for VITADEE™ 100 SD marks a significant milestone for Fermenta. It reinforces our commitment to the benchmarks of regulatory compliance by growing our product portfolio whilst strengthening our position as an established global partner in the field of Vitamin D3. This accreditation also enables us to move further up the value chain and stands as yet another testament to our focus on excellence, innovation, and trust." This recognition further enhances Fermenta's international footprint and our capability to deliver products that meet the highest global quality and regulatory standards. It represents another step forward in our mission to expand our global presence and create meaningful impact across the health and nutrition industry. About Fermenta Biotech Limited : Founded in 1951, Fermenta Biotech Limited (Fermenta) possesses a growing portfolio of nutrition including Customized Premixes, Fortified Rice Kernel (FRK) and other nutritional ingredients. Apart from its nutrition portfolio, Fermenta is one of the world's leading manufacturers of Vitamin D3. It caters to over 400 customers across 60 countries with a worldwide distribution network for a variety of applications such as pharmaceuticals, dietary and nutritional supplements, food, animal nutrition and rodenticides. Fermenta's manufacturing facilities in Kullu, Dahej and Tirupati are certified by global accreditations, and its world class R & D centre is located at Thane. Fermenta also possesses expertise in green chemistry such as enzymes for antibiotic synthesis, other niche APIs and environmental solutions. For more information about Fermenta and its business, please visit our website Safe Harbor : Statements in this document relating to future status, events, or circumstances, including but not limited to statements about plans and objectives, the progress and results of research and development, potential project characteristics, project potential and target dates for project related issues are forward-looking statements based on estimates and the anticipated effects of future events on current and developing circumstances. Such statements are subject to numerous risks and uncertainties and are not necessarily predictive of future results. Actual results may differ materially from those anticipated in the forward-looking statements. Fermenta assumes no obligation to update forward-looking statements to reflect actual results, changed assumptions or other factors.
News18
28-07-2025
- Entertainment
- News18
Fans Urge Authorities To Convert RD Burman's Childhood Home Into Museum, Launch Petition
Last Updated: Fans of SD and RD Burman urge authorities to convert their neglected Kolkata childhood home into a museum. Despite appeals, the house remains in disrepair. Music lovers are coming together to save a piece of history, that is, the childhood home of legendary composers SD Burman and RD Burman in Kolkata. The house, located at 36/1 South End Park, has fallen into a state of neglect. Fans are now urging authorities to convert it into a museum. To push for action, a group of fans has launched an online petition that has already gathered over 7,000 signatures within a week. They believe that the house should be preserved as a cultural landmark. 'This house is not just brick and mortar — it echoes with melodies that shaped Indian music. Instead of being lost to time, it deserves to be turned into a living museum, a cultural space that honours their genius and nurtures future talent," the petition says. Back in January 2021, West Bengal Chief Minister Mamata Banerjee had renamed the road outside the house to 'Sangeet Sarani", and there were talks of turning the property into a museum. But according to family members, nothing came of those plans. RD Burman's uncle, Abhijit Dasgupta, shared his disappointment in a conversation with The Telegraph. 'We were promised a museum. We were told a blue plaque would be installed. In 2021, they even renamed the street Sangeet Sarani. But nothing beyond symbolism has happened." He also questioned, 'If the Ministry of External Affairs can offer help to restore a Ray-linked building in Mymensingh, why can't our own state protect this house steeped in musical history?" When asked about the petition, Swapan Samaddar, Member, Mayor-in-Council (Environment & Heritage), said, 'I have not received any such petition. If I do, I'll take necessary steps." He added that he wasn't in charge of the heritage portfolio back in 2021. But fans are not giving up. Dasgupta, who started the petition, said firmly, 'This time we're determined to see it through." RD Burman was one of the most celebrated music directors in Indian cinema. Active from the 1960s to the 1990s, he composed music for over 330 films and played a big role in shaping the sound of Hindi film music. Burman worked closely with some of the biggest singing legends like Mukesh, Kishore Kumar, Lata Mangeshkar, Asha Bhosle, and Mohammed Rafi. He also shared a special creative partnership with lyricist Gulzar/ Rahul Dev Burman was the only son of renowned composer Sachin Dev Burman and lyricist Meera Dev Burman. First Published: July 28, 2025, 07:45 IST Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
Associated Press
23-07-2025
- Business
- Associated Press
Avel eCare Appoints Martainn Lenhardt as Chief Financial Officer to Lead Financial Strategy Amid Rapid Growth and Innovation
SIOUX FALLS, SD / ACCESS Newswire / July 23, 2025 / Avel eCare, a leading provider of telemedicine services in the United States, today announced the appointment of Martainn Lenhardt as Chief Financial Officer (CFO). Lenhardt brings over 20 years of healthcare finance experience to the role, where he will oversee Avel's financial strategy, operations, and performance during a pivotal era of innovation and nationwide expansion. Lenhardt joins Avel eCare following his tenure as VP of Finance at Lyric and senior leadership roles at Change Healthcare, where he managed a $480 million business unit and was instrumental in driving growth and improving margins. He is widely recognized for his expertise in strategic growth, mergers and acquisitions, and optimizing global operations. His ability to turn complexity into opportunity and build agile, purpose-driven teams will be instrumental in advancing Avel's mission. 'Avel eCare is transforming how healthcare is delivered across the country,' said Lenhardt. 'It's an honor to join this team and help scale a model that brings high-quality, virtual care to every corner of the nation.' This appointment comes at a time of unprecedented momentum for Avel eCare. In the past two years alone, Avel has launched new service lines, secured exclusive partnerships with organizations like Amwell and Cibolo Health, and expanded services to more than 46 states. The company continues to innovate with in-ambulance telehealth, ICU solutions, and programs that support EMS, law enforcement, and correctional health, making care more accessible, cost-effective, and consistent, especially in rural and underserved areas. The new CFO joins an accomplished executive team committed to advancing healthcare access and outcomes across the country. Avel's leadership includes: About Avel eCare Avel eCare is a national leader in technology-enabled clinical services delivered through telemedicine, offering provider-to-provider virtual care solutions that expand clinical capacity and improve outcomes across the healthcare industry. With more than 30 years of innovation, Avel's board-certified clinicians partner with hospitals, clinics, long-term care facilities, schools, EMS agencies, and correctional health systems nationwide to bring high-quality care to patients when and where it's needed most. Learn more at: Media Contact: Jessica Gaikowski Avel eCare [email protected] SOURCE: Avel eCare press release
Newsweek
11-07-2025
- Automotive
- Newsweek
Ford Recalls More Than 850,000 Cars: These Models Are Impacted
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Ford has recalled more than 850,000 vehicles across the United States due to a possible defect in the low-pressure fuel pump that could cause engines to stall while driving. The recall, which impacts a wide range of Ford and Lincoln-branded models produced in recent years, was announced by the National Highway Traffic Safety Administration (NHTSA) on July 8. Owners affected by the recall will begin receiving notifications by mail from Monday, July 14, but an official fix has not yet been disclosed by the carmaker. Newsweek contacted Ford for comment by email outside of regular working hours on Friday. A Ford Bronco on display in New York in 2023. A Ford Bronco on display in New York in 2023. NDZ/STAR MAX/IPx Why It Matters Engine stalling while a vehicle is driving can increase the risk of collisions, especially at high speeds or in dense traffic. Although Ford has reported no known accidents or injuries linked to the issue, drivers are being urged to remain vigilant for potential warning signs, including poor engine performance, reduced power or an illuminated check engine light. What To Know Ford indicated that failure of the low-pressure fuel pump could lead to an engine stalling while at rest or driving. The NHTSA said that fuel pump failure is more likely to occur "in low fuel or warm weather and hot fuel conditions in the fuel tank." It added: "Loss of fuel pressure and flow from the low-pressure fuel pump can be due to internal contamination of the jet pump, specifically in low fuel conditions, and reduced fuel pump internal clearances that result in an increase of internal friction and sensitivity to vapor lock." Which Models Are Impacted? The recall affects specific Ford and Lincoln models manufactured in recent years. According to NHTSA documents, these include: 2021–2023 Ford Bronco 2021–2023 Ford Explorer 2021–2023 Lincoln Aviator 2021–2023 Ford F-250 SD, F-350 SD, F-450 SD, and F-550 SD 2021–2022 Lincoln Navigator 2021–2022 Ford Mustang 2021–2022 Ford F-150 Some 2022 Ford Expedition models Ford estimated that roughly 10 percent of the 850,318 vehicles included in the recall may be affected by the faulty fuel pump. What People Are Saying The NHTSA said in its safety recall report: "Prior to fuel pump failure, the customer may experience poor engine performance (misfiring or running rough), a check engine light, or a reduction in engine power. Fuel pump failure is more likely to occur in low fuel or warm weather and hot fuel conditions in the fuel tank." It added in a letter to Ford: "Under 49 U.S.C. § 30112(a)(3), it is illegal for a manufacturer, to sell, offer for sale, import, or introduce or deliver into interstate commerce, a motor vehicle or item of motor vehicle equipment that contains a safety defect once the manufacturer has notified NHTSA about that safety defect. This prohibition does not apply once the motor vehicle or motor vehicle equipment has been remedied according to the manufacturer's instructions." What Happens Next Ford will notify affected owners from July 14 about the potential risks. The carmaker stated that once a solution is available, impacted owners will receive a second letter instructing them on how to obtain a free repair at authorized dealerships. Ongoing updates from Ford and federal safety authorities are expected as work on the remedy progresses. This article includes reporting by The Associated Press.
